Table 2.
r | p value | r | p value | ||
---|---|---|---|---|---|
Age (years) | 0.02 | 0.93 | Gene expression | ||
BMI (kg/m2) | 0.01 | 0.95 | ADIPOQ | −0.38 | 0.06 |
WHR | 0.02 | 0.94 | CASP3 | 0.56 | <0.01 |
CCL3 | −0.34 | 0.18 | |||
Serum parameters | CD144 | −0.29 | 0.14 | ||
Triglycerides (mg/dl) | 0.20 | 0.33 | CD3E | 0.30 | 0.13 |
Total cholesterol (mg/dl) | −0.23 | 0.25 | CD40 | 0.34 | 0.09 |
HDL-C (mg/dl) | −0.26 | 0.20 | CD68 | −0.29 | 0.15 |
LDL-C (mg/dl) | −0.25 | 0.21 | CIDEA | -0.37 | 0.06 |
ALT (U/l) | 0.23 | 0.21 | FGF1 | −0.33 | 0.10 |
GGT (U/l) | 0.31 | 0.13 | HLA-DR | 0.10 | 0.63 |
Glucose (mg/dl) | 0.39 | 0.04 | IGF1 | −0.43 | 0.03 |
Insulin (μU/ml) | 0.00 | 0.98 | IL10 | −0.18 | 0.40 |
C-peptide (ng/ml) | −0.03 | 0.87 | IL1B | −0.17 | 0.42 |
HOMA-IR | 0.02 | 0.91 | IL6 | −0.33 | 0.13 |
CRP (mg/dl) | 0.12 | 0.56 | IRS2 | −0.15 | 0.47 |
HbA1c (%) | −0.03 | 0.90 | PLIN1 | −0.44 | 0.03 |
Myostatin (ng/ml) | 0.22 | 0.37 | PPARG | −0.48 | 0.01 |
IL-6 (pg/ml) | 0.26 | 0.20 | SLC2A4 | −0.54 | <0.01 |
Adiponectin (μg/ml) | 0.03 | 0.90 | VEGFC | −0.27 | 0.18 |
TNF (pg/ml) | 0.07 | 0.72 | |||
IGF1 (ng/ml) | −0.25 | 0.20 | |||
Albumin (mg/dl) | 0.24 | 0.21 | |||
Elastic net regression | Selected variables | B coefficients | |||
Glucose (mg/ml) | 0.002 | ||||
CASP3 (a.u.) | 0.308 | ||||
CD40 (a.u.) | 0.033 | ||||
SLC2A4 (a.u.) | −0.85 |
Significant correlations are highlighted in italics. B coefficients represent the unstandardized regression coefficient of the independent variables, which describe the ddCt values of TNF via elastic net regression. Elastic net parameters were chosen to minimize the mean squared error of the linear regression as following: the relative strength of the L1 and L2 penalty term α = 0.86 and the regression penalty λ = 0.30. The intercept of the regression was 0.950
r Pearson correlation coefficient, p significance level, ALT alanine transaminase, CRP C-reactive protein, GGT gamma-glutamyl-transferase, HbA1c hemoglobin A1c, HDL-C high-density lipoprotein cholesterol, HOMA-IR homeostatic model assessment–insulin resistance, LDL-C low-density lipoprotein cholesterol, WHR waist to hip ratio, a.u. arbitrary units